A preliminary study of dopamine-mediated prolactin inhibition in generalised social phobia

Psychiatry Research

Volumn 111, Issue 1, 2002, Pages 87-92

  Condren, Rita M ^a   Sharifi, Neda ^b   Thakore, Jogin H ^a  

^a St Vincent's Hospital Ireland   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Cortisol; Prolactin; Quinagolide

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; PROLACTIN; QUINAGOLIDE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; DRUG RESPONSE; FEMALE; HORMONE INHIBITION; HORMONE RESPONSE; HUMAN; MALE; PRIORITY JOURNAL; RECEPTOR SENSITIVITY; SEX; SOCIAL PHOBIA; STATISTICAL SIGNIFICANCE; TUBEROHYPOPHYSEAL TRACT;

ADULT; AMINOQUINOLINES; DOPAMINE AGONISTS; FEMALE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PHOBIC DISORDERS; PROLACTIN; RECEPTORS, DOPAMINE D2;

EID: 0037025876     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(02)00103-8     Document Type: Article

References (44)

1. Regulation of the tuberoinfundibular and nigrostriatal systems
2. The neurobiology of social phobia
3. Social phobia: Diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment
4. Cultures of GH3 cells are functionally heterogeneous: Thyrotropin-releasing hormone, estradiol and cortisol cause some reciprocal shifts in the proportions of growth hormone and prolactin secretors
5. 3H]-CV205-502
6. The boundary of social phobia
7. The role of cortisol in spontaneous and stimulated prolactin release
8. Impact of cortisol on buspirone stimulated prolactin release: A double-blind placebo-controlled study
9. Treatment of social phobia with bupropion (letter)
10. Glucocorticoid and thyroid hormones transcriptionally regulate growth hormone gene expression
11. Hormonal effects of CV205-502, a novel octahydrobenzo[g] quinoline with potent dopamine agonist properties
12. A novel octahydrobenzo [g] quinoline, CV 205-502, with potent dopamine agonist properties
13. Specific effect of CV 205-502, a potent nonergot dopamine agonist, during a combined anterior pituitary function test
14. DSM-III-R subtypes of social phobia. Comparison of generalized social phobics and public speaking phobics
15. (-)N-[(11)C]propyl-norapomorphine: A positron-labeled dopamine agonist for PET imaging of D(2)receptors
16. Plasma and CSF HVA levels in panic patients with comorbid social phobia
17. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
18. Regulation of prolactin secretion at the level of the lactotroph
19. Responses of 'generalized' and 'discrete' social phobics during public speaking
20. Possible dopamine dysregulation in social phobia and atypical depression
21. Social phobia
22. Salivary cortisol levels in socially phobic adolescent girls
23. Neurobiological mechanisms of social anxiety disorder
24. School avoidance and social phobia triggered by haloperidol in patients with Tourette's syndrome
25. Six-month prevalence of psychiatric disorders in three communities: 1980-1982
26. Long-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma
27. Brain mechanisms of social anxiety disorder
28. Levels of urinary free cortisol in social phobia
29. Efficacy of quinagolide in resistance to dopamine agonists: Results of a multicenter study. Club de l'Hypophyse
30. Low dopamine D2 receptor binding potential in social phobia
31. Quinagolide in the management of prolactinoma
32. Neurobiological perspectives on social phobia: From affiliation to zoology
33. Anxiety disorders in patients with Parkinson's disease
34. Setting diagnostic thresholds for social phobia: Considerations from a community study of social anxiety
35. Neuroendocrine responsivity to monoaminergic system probes in generalized social phobia
36. Dopamine reuptake site densities in patients with social phobia
37. Normal urinary free cortisol and postdexamethasone cortisol in social phobia: Comparison to normal volunteers
38. Antiparkinsonian dopamine agonists: A review of the pharmacokinetics and neuropharmacology in animals and humans
39. Effects of hydrocortisone on brain 5HT function and sleep